3 C
New York
Thursday, February 12, 2026

BMO reaffirms Outperform rating for Eli Lilly stock following positive weight loss data


Eli Lilly stock rating reiterated at Outperform by BMO on weight loss data

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles